GlassScriptPhysician profile
Lucas Terry
NPI 1063105294
$4,426.49
in general payments reported to CMS, 2019-2025
16 companies · $1,709 in 2025
The $1,709 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $861 · 2024: $1,856 · 2025: $1,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,151 · Education: $276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,150.59 |
| Education | $275.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $895.93 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $647.87 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $529.32 | 2023-2025 | Ilumya, Blu-U |
| Janssen Biotech, INC. | $514.15 | 2023-2025 | Tremfya |
| Genzyme Corporation | $470.93 | 2023-2025 | |
| Ucb, INC. | $320.37 | 2023-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $316.28 | 2023-2024 | Sotyktu |
| Pfizer INC. | $157.47 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $123.45 | 2024-2025 | Dupixent |
| Amgen INC. | $119.86 | 2023-2025 | Otezla, Otezla |
| Lilly USA, LLC | $115.72 | 2024 | Taltz, Ebglyss, Olumiant |
| Incyte Corporation | $90.47 | 2023-2025 | Opzelura |
| Galderma Laboratories, L.P. | $41.56 | 2025 | Nemluvio |
| Organon LLC | $36.50 | 2025 | Vtama |
| Arcutis Biotherapeutics, INC. | $24.04 | 2024 | Zoryve |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $22.57 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Terry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.